These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17525254)

  • 1. SRY-related HMG box 9 regulates the expression of Col4a2 through transactivating its enhancer element in mesangial cells.
    Sumi E; Iehara N; Akiyama H; Matsubara T; Mima A; Kanamori H; Fukatsu A; Salant DJ; Kita T; Arai H; Doi T
    Am J Pathol; 2007 Jun; 170(6):1854-64. PubMed ID: 17525254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of the Sry-related factor SOX6 contributes to bone morphogenetic protein-2-induced chondroblastic differentiation of C3H10T1/2 cells.
    Fernández-Lloris R; Viñals F; López-Rovira T; Harley V; Bartrons R; Rosa JL; Ventura F
    Mol Endocrinol; 2003 Jul; 17(7):1332-43. PubMed ID: 12677004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PIAS1 interacts with and represses SOX9 transactivation activity.
    Oh HJ; Kido T; Lau YF
    Mol Reprod Dev; 2007 Nov; 74(11):1446-55. PubMed ID: 17440973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor Sox9 is degraded by the ubiquitin-proteasome system and stabilized by a mutation in a ubiquitin-target site.
    Akiyama H; Kamitani T; Yang X; Kandyil R; Bridgewater LC; Fellous M; Mori-Akiyama Y; de Crombrugghe B
    Matrix Biol; 2005 Jan; 23(8):499-505. PubMed ID: 15694126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Col9a1 enhancer element activated by two interdependent SOX9 dimers.
    Genzer MA; Bridgewater LC
    Nucleic Acids Res; 2007; 35(4):1178-86. PubMed ID: 17264118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjacent DNA sequences modulate Sox9 transcriptional activation at paired Sox sites in three chondrocyte-specific enhancer elements.
    Bridgewater LC; Walker MD; Miller GC; Ellison TA; Holsinger LD; Potter JL; Jackson TL; Chen RK; Winkel VL; Zhang Z; McKinney S; de Crombrugghe B
    Nucleic Acids Res; 2003 Mar; 31(5):1541-53. PubMed ID: 12595563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox9 coordinates a transcriptional network in pancreatic progenitor cells.
    Lynn FC; Smith SB; Wilson ME; Yang KY; Nekrep N; German MS
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10500-5. PubMed ID: 17563382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-range activation of Sox9 in Odd Sex (Ods) mice.
    Qin Y; Kong LK; Poirier C; Truong C; Overbeek PA; Bishop CE
    Hum Mol Genet; 2004 Jun; 13(12):1213-8. PubMed ID: 15115764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-activation of the mouse cartilage-derived retinoic acid-sensitive protein gene by Sox9.
    Xie WF; Zhang X; Sakano S; Lefebvre V; Sandell LJ
    J Bone Miner Res; 1999 May; 14(5):757-63. PubMed ID: 10320524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an enhancer sequence within the first intron required for cartilage-specific transcription of the alpha2(XI) collagen gene.
    Liu Y; Li H; Tanaka K; Tsumaki N; Yamada Y
    J Biol Chem; 2000 Apr; 275(17):12712-8. PubMed ID: 10777565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular action and regulation of the testis-determining factors, SRY (sex-determining region on the Y chromosome) and SOX9 [SRY-related high-mobility group (HMG) box 9].
    Harley VR; Clarkson MJ; Argentaro A
    Endocr Rev; 2003 Aug; 24(4):466-87. PubMed ID: 12920151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three high mobility group-like sequences within a 48-base pair enhancer of the Col2a1 gene are required for cartilage-specific expression in vivo.
    Zhou G; Lefebvre V; Zhang Z; Eberspaecher H; de Crombrugghe B
    J Biol Chem; 1998 Jun; 273(24):14989-97. PubMed ID: 9614106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene.
    Lefebvre V; Huang W; Harley VR; Goodfellow PN; de Crombrugghe B
    Mol Cell Biol; 1997 Apr; 17(4):2336-46. PubMed ID: 9121483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-range upstream and downstream enhancers control distinct subsets of the complex spatiotemporal Sox9 expression pattern.
    Bagheri-Fam S; Barrionuevo F; Dohrmann U; Günther T; Schüle R; Kemler R; Mallo M; Kanzler B; Scherer G
    Dev Biol; 2006 Mar; 291(2):382-97. PubMed ID: 16458883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MAPK/AP-1-dependent regulation of PAI-1 gene expression by TGF-beta in rat mesangial cells.
    Guo B; Inoki K; Isono M; Mori H; Kanasaki K; Sugimoto T; Akiba S; Sato T; Yang B; Kikkawa R; Kashiwagi A; Haneda M; Koya D
    Kidney Int; 2005 Sep; 68(3):972-84. PubMed ID: 16105028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sox9, a key transcription factor of bone morphogenetic protein-2-induced chondrogenesis, is activated through BMP pathway and a CCAAT box in the proximal promoter.
    Pan Q; Yu Y; Chen Q; Li C; Wu H; Wan Y; Ma J; Sun F
    J Cell Physiol; 2008 Oct; 217(1):228-41. PubMed ID: 18506848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse.
    Ng LJ; Wheatley S; Muscat GE; Conway-Campbell J; Bowles J; Wright E; Bell DM; Tam PP; Cheah KS; Koopman P
    Dev Biol; 1997 Mar; 183(1):108-21. PubMed ID: 9119111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of regulatory target selection by the SOX high-mobility-group domain proteins as revealed by comparison of SOX1/2/3 and SOX9.
    Kamachi Y; Cheah KS; Kondoh H
    Mol Cell Biol; 1999 Jan; 19(1):107-20. PubMed ID: 9858536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination.
    Gasca S; Canizares J; De Santa Barbara P; Mejean C; Poulat F; Berta P; Boizet-Bonhoure B
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11199-204. PubMed ID: 12169669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type IV Collagen and SOX9 Are Molecular Targets of BET Inhibition in Experimental Glomerulosclerosis.
    Morgado-Pascual JL; Suarez-Alvarez B; Marchant V; Basantes P; Tharaux PL; Ortiz A; Lopez-Larrea C; Ruiz-Ortega M; Rayego-Mateos S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.